Mild to Moderate Depression Clinical Trial
Official title:
Descriptive Study of a Phytotherapy Management Strategy for Mild to Moderate Major Depression With Phytostandard® Rhodiola-Saffron : a Combination of Rhodiola and Saffron Extracts.
The purpose of the study is to describe, over 6 weeks, the evolution of depressive symptoms in patients with mild to moderate major depression in a strategy with Phytostandard® Rhodiola-Saffron supplementation
For this study, 52 patients are going to be included. They will have a supplementation of
Phytostandard® rhodiola/saffron, from 2 tablets per day during 42 days.
on the one hand, during the two visits (inclusion and follow-up), the investigator completes
the Hamilton Depression Scale (HAM-D) and the Clinical Global Impression (CGI). During the
inclusion visit, he completes with his patient CIM-10 for depression diagnostic.
on the other hand, patients complete HAD 4 times : just after the inclusion visit, at day 14,
at day 28 and just before the follow-up visit. He completes the Patient Global Impression too
at each time.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03471754 -
Pilot Study Using Transcranial Electrostimulation (TESA-HB) Therapy for the Treatment of Depressive Symptoms
|
N/A | |
| Recruiting |
NCT05118828 -
Guided Internet-based Interventions in Primary Care Effectiveness-implementation Randomized Controlled Trial
|
N/A | |
| Completed |
NCT03238872 -
Trial of Prompt Mental Health Care
|
N/A |